Physician profile
Manuel Rodriguez
NPI 1477729846
$5,580.83
in general payments reported to CMS, 2019-2025
15 companies · $1,623 in 2025
The $1,623 reported for 2025 was more than what 80% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $699 · 2020: $242 · 2021: $767 · 2022: $707 · 2023: $821 · 2024: $723 · 2025: $1,623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,052 · Travel and Lodging: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,052.42 |
| Travel and Lodging | $114.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $4,566.04 | 2019-2025 | Puraply, Apligraf, Simplimax |
| Djo, LLC | $288.63 | 2019-2021 | |
| Integra Lifesciences Corporation | $230.48 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kci USA, INC. | $85.35 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $83.21 | 2020-2022 | |
| Smith+Nephew, INC. | $56.94 | 2019-2024 | Collagenase Santyl |
| Next Science LLC | $50.76 | 2024 | Xperience, Surgx, Blastx |
| Mimedx Group, INC. | $49.60 | 2024 | |
| Amgen INC. | $44.45 | 2025 | Krystexxa |
| Ets Wound Care LLC | $39.96 | 2023-2024 | Mirragen Advanced Wound Matrix |
| Reprise Biomedical, INC. | $37.75 | 2023 | Miro3d |
| Alfasigma USA, INC. | $17.98 | 2021 | |
| Paratek Pharmaceuticals, INC. | $15.73 | 2022 | |
| Sebela Pharmaceuticals INC. | $13.95 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.